ghk-cu typical dose mg per day subcutaneous daily dose of ghk cu peptide GHK-Cu HGH & Peptides GHK-CU Peptide Dosage: Complete Guide

Chronic potentiation of a proliferative pathway is a reason researchers flag oncological caution but that is mechanistic reasoning, not a demonstrated effect

Mechanism Diagram GHK-Cu vs Growth Peptides (Key Differences) GHK-Cu - Copper binding tripeptide - Acts locally in tissue - Modulates gene expression and ECM remodelling - Not endocrine - Does not elevate GH or IGF-1 GH Secretagogues (e.g., Ipamorelin, Hexarelin, MK-677) - Act via endocrine receptors - Stimulate systemic GH release - Increase IGF-1 - Primarily hormonal These compounds operate in completely different biological domains

Telomerase activity and telomere dynamics likely function within a normal physiological range, meaning that cellular senescence processes develop at rates similar to the broader population

The two mechanisms are complementary without overlap, making this a clean combination